Startseite Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners

  • Ye Tian EMAIL logo , Tom K. Tong , Giuseppe Lippi , Chuanye Huang , Qingde Shi und Jinlei Nie
Veröffentlicht/Copyright: 6. April 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: This study investigated the changes in biomarkers of renal function and the corresponding estimated glomerular filtration rate (eGFR) in 10 male adolescent (16.2±0.6 years) trained runners during early and late recovery periods after an all-out 21-km run.

Methods: Venous blood samples were taken immediately before, and at 2-h, 4-h, and 24-h following the 21-km run. Samples were analyzed for hemoglobin (Hb) and hematocrit (Hct), and serum urea (U), creatinine (Cr), creatine kinase (CK) and lactate dehydrogenase (LDH). U/Cr ratio, eGFR, and plasma volume change (%ΔPV) were calculated based on the associated measured variables.

Results: At 2-h and 4-h, there were increases (26%–146%) in U, Cr, U/Cr, CK, and LDH, and decreases (8%–13%) in Hb and Hct, as compared with the corresponding pre-exercise values. The calculated %ΔPV increased by 17% while the eGFR decreased 20% from the corresponding pre-exercise value, respectively. At 24-h, the changes of the blood variables and renal function parameters observed at early recovery period were sustained.

Conclusions: Taken together, the findings of this study suggest that mild decline in renal function occurred during the early recovery period following the 21-km run. The decline in renal function did not return to normal during the later recovery period.


Corresponding author: Ye Tian, China Institute of Sport Science, 11 Tiyuguan Road, Chongwen District, Beijing 100061, P.R. China Phone: +86-10-8718-2528, Fax: +86-10-8718-2600

Received: 2010-11-16
Accepted: 2010-12-26
Published Online: 2011-04-6
Published in Print: 2011-06-01

©2011 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Editors’ and Publisher’s Note
  2. CCLM Award for The Most Cited Paper Recently Published
  3. Reviews
  4. Some views on proteomics in diabetes
  5. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics
  6. Minireviews
  7. Low-density lipoprotein receptor-related protein 1: new functions for an old molecule
  8. Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
  9. Opinion Paper
  10. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization
  11. General Clinical Chemistry and Laboratory Medicine
  12. Use of a fully automated immunoassay for celiac disease screening in a pediatric population
  13. Evaluation of four commercial biuret reagent kits of serum total protein by the American Association for Clinical Chemistry reference measurement procedure
  14. Renal function parameters during early and late recovery periods following an all-out 21-km run in trained adolescent runners
  15. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia
  16. The severity of pseudohyperkalaemia is not dependent upon the stage of chronic kidney disease: a prospective study
  17. Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
  18. Perchlorate (Irenat®) may falsely lower measured ionised calcium
  19. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
  20. A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
  21. Reference Values and Biological Variations
  22. Reference change values for monitoring dehydration
  23. Cancer Diagnostics
  24. Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis
  25. Plasma concentrations of angiogenetic factors and angiogenetic inhibitors in patients with ductal pancreatic neoplasms. A pilot study
  26. Cardiovascular Diseases
  27. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study
  28. Letters to the Editor
  29. Results of a pilot external quality assessment study on free protoporphyrin in erythrocytes
  30. Trueness assessment of Korean nation-wide glucose proficiency testing
  31. Genetic polymorphism of cytochrome P450 1A1 in a northern Italian population: high frequency of the CYP1A1*2C allele
  32. Prestaining of PCR products with SYBR Green for agarose gel electrophoresis: advantages and limitations
  33. A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells
  34. Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial
  35. Evidence on the cause of false positive troponin I results with the Beckman AccuTnI method
  36. Cross-reactivity of insulin analogs with the Diasorin Liaison Insulin assay
  37. Improved turnaround time for neonatal hematology profile tests (complete blood count) using a new microcollection tube
  38. Erratum
  39. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.172/pdf
Button zum nach oben scrollen